Online inquiry

IVTScrip™ mRNA-Human AAMDC, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK7515MR)

This product GTTS-WK7515MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & N1-Methylpseudo-UTP. It ecodes the AAMDC protein. This product can be used in Retinoid acid signaling-responsive fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases N1-Methylpseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001316957.3
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 28971
UniProt ID Q9H7C9
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human AAMDC, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) (GTTS-WK7515MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK8030MR IVTScrip™ mRNA-Human Additional GABA Compounds, (Cap 0, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA Additional GABA Compounds
GTTS-WK28021MR IVTScrip™ mRNA-Human ARHGEF6, (Cap 1, 2-Thio-UTP, 30 nt-poly(A)) mRNA ARHGEF6
GTTS-WK4599MR IVTScrip™ mRNA-Human CD59, (Cap 1, 2-Thio-UTP, 120 nt-poly(A)) mRNA CD59
GTTS-WK13027MR IVTScrip™ mRNA-Human ACKR3, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ACKR3
GTTS-WK13146MR IVTScrip™ mRNA-Human ADGRL2, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ADGRL2
GTTS-WK12585MR IVTScrip™ mRNA-Human AFG3L2, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA AFG3L2
GTTS-WK13168MR IVTScrip™ mRNA-Human ADRB2, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ADRB2
GTTS-WK15823MR IVTScrip™ mRNA-Human ANKRD37, (Cap 0, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ANKRD37
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW